vs

Side-by-side financial comparison of COMTECH TELECOMMUNICATIONS CORP (CMTL) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.

Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $111.0M, roughly 1.5× COMTECH TELECOMMUNICATIONS CORP). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -4.1%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -9.0%).

Comtech Telecommunications Corp is a global provider of advanced communication technologies, including satellite communication systems, terrestrial network infrastructure, and location-based services. It serves government, defense, mobile network operator, and enterprise clients across North America, Europe, and Asia Pacific, focusing on reliable, secure connectivity solutions for critical use cases.

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

CMTL vs ESPR — Head-to-Head

Bigger by revenue
ESPR
ESPR
1.5× larger
ESPR
$168.4M
$111.0M
CMTL
Growing faster (revenue YoY)
ESPR
ESPR
+147.8% gap
ESPR
143.7%
-4.1%
CMTL
Faster 2-yr revenue CAGR
ESPR
ESPR
Annualised
ESPR
10.6%
-9.0%
CMTL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CMTL
CMTL
ESPR
ESPR
Revenue
$111.0M
$168.4M
Net Profit
$-15.9M
Gross Margin
33.1%
Operating Margin
-2.5%
50.6%
Net Margin
-14.3%
Revenue YoY
-4.1%
143.7%
Net Profit YoY
89.3%
EPS (diluted)
$-0.67
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMTL
CMTL
ESPR
ESPR
Q4 25
$111.0M
$168.4M
Q3 25
$130.4M
$87.3M
Q2 25
$126.8M
$82.4M
Q1 25
$126.6M
$65.0M
Q4 24
$115.8M
$69.1M
Q3 24
$126.2M
$51.6M
Q2 24
$128.1M
$73.8M
Q1 24
$134.2M
$137.7M
Net Profit
CMTL
CMTL
ESPR
ESPR
Q4 25
$-15.9M
Q3 25
$7.9M
$-31.3M
Q2 25
$33.9M
$-12.7M
Q1 25
$-48.7M
$-40.5M
Q4 24
$-148.4M
Q3 24
$-90.8M
$-29.5M
Q2 24
$2.8M
$-61.9M
Q1 24
$-10.6M
$61.0M
Gross Margin
CMTL
CMTL
ESPR
ESPR
Q4 25
33.1%
Q3 25
31.2%
Q2 25
30.7%
Q1 25
26.7%
Q4 24
12.5%
Q3 24
21.5%
Q2 24
30.4%
Q1 24
32.2%
Operating Margin
CMTL
CMTL
ESPR
ESPR
Q4 25
-2.5%
50.6%
Q3 25
1.4%
-11.4%
Q2 25
-1.2%
8.6%
Q1 25
-8.1%
-34.0%
Q4 24
-111.5%
-6.4%
Q3 24
-64.6%
-31.0%
Q2 24
-2.7%
3.5%
Q1 24
2.2%
52.5%
Net Margin
CMTL
CMTL
ESPR
ESPR
Q4 25
-14.3%
Q3 25
6.1%
-35.9%
Q2 25
26.8%
-15.4%
Q1 25
-38.5%
-62.2%
Q4 24
-128.2%
Q3 24
-71.9%
-57.2%
Q2 24
2.2%
-83.9%
Q1 24
-7.9%
44.3%
EPS (diluted)
CMTL
CMTL
ESPR
ESPR
Q4 25
$-0.67
$0.32
Q3 25
$-0.41
$-0.16
Q2 25
$-0.49
$-0.06
Q1 25
$-0.76
$-0.21
Q4 24
$-5.29
$-0.14
Q3 24
$-3.48
$-0.15
Q2 24
$-0.04
$-0.33
Q1 24
$-1.07
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMTL
CMTL
ESPR
ESPR
Cash + ST InvestmentsLiquidity on hand
$43.6M
$167.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$85.6M
$-302.0M
Total Assets
$734.1M
$465.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMTL
CMTL
ESPR
ESPR
Q4 25
$43.6M
$167.9M
Q3 25
$40.0M
$92.4M
Q2 25
$28.4M
$86.1M
Q1 25
$26.7M
$114.6M
Q4 24
$29.6M
$144.8M
Q3 24
$32.4M
$144.7M
Q2 24
$27.2M
$189.3M
Q1 24
$40.0M
$226.6M
Stockholders' Equity
CMTL
CMTL
ESPR
ESPR
Q4 25
$85.6M
$-302.0M
Q3 25
$104.4M
$-451.4M
Q2 25
$115.4M
$-433.5M
Q1 25
$128.7M
$-426.2M
Q4 24
$150.4M
$-388.7M
Q3 24
$306.3M
$-370.2M
Q2 24
$406.4M
$-344.2M
Q1 24
$407.0M
$-294.3M
Total Assets
CMTL
CMTL
ESPR
ESPR
Q4 25
$734.1M
$465.9M
Q3 25
$740.8M
$364.0M
Q2 25
$751.1M
$347.1M
Q1 25
$770.6M
$324.0M
Q4 24
$793.2M
$343.8M
Q3 24
$793.2M
$314.1M
Q2 24
$991.0M
$352.3M
Q1 24
$996.8M
$373.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMTL
CMTL
ESPR
ESPR
Operating Cash FlowLast quarter
$8.1M
$45.2M
Free Cash FlowOCF − Capex
$4.8M
FCF MarginFCF / Revenue
4.3%
Capex IntensityCapex / Revenue
2.9%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$12.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMTL
CMTL
ESPR
ESPR
Q4 25
$8.1M
$45.2M
Q3 25
$11.4M
$-4.3M
Q2 25
$2.3M
$-31.4M
Q1 25
$-234.0K
$-22.6M
Q4 24
$-21.8M
$-35.0M
Q3 24
$-9.5M
$-35.3M
Q2 24
$-3.8M
$-7.2M
Q1 24
$-26.7M
$53.8M
Free Cash Flow
CMTL
CMTL
ESPR
ESPR
Q4 25
$4.8M
Q3 25
$9.4M
Q2 25
$-160.0K
Q1 25
$-1.9M
Q4 24
$-24.2M
Q3 24
$-12.4M
$-35.5M
Q2 24
$-6.5M
$-7.3M
Q1 24
$-30.9M
$53.8M
FCF Margin
CMTL
CMTL
ESPR
ESPR
Q4 25
4.3%
Q3 25
7.2%
Q2 25
-0.1%
Q1 25
-1.5%
Q4 24
-20.9%
Q3 24
-9.8%
-68.7%
Q2 24
-5.0%
-9.9%
Q1 24
-23.0%
39.0%
Capex Intensity
CMTL
CMTL
ESPR
ESPR
Q4 25
2.9%
0.0%
Q3 25
1.6%
0.0%
Q2 25
1.9%
0.0%
Q1 25
1.3%
0.0%
Q4 24
2.1%
0.0%
Q3 24
2.3%
0.3%
Q2 24
2.1%
0.1%
Q1 24
3.2%
0.1%
Cash Conversion
CMTL
CMTL
ESPR
ESPR
Q4 25
Q3 25
1.45×
Q2 25
0.07×
Q1 25
Q4 24
Q3 24
Q2 24
-1.36×
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMTL
CMTL

Satellite And Space Communications Segment$55.1M50%
Transferred At Point In Time$39.4M36%
Satellite And Space Communications$16.3M15%
Terrestrial And Wireless Networks$1.1M1%

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

Related Comparisons